Bausch & Lomb (STU:S2L) Accumulated Depreciation : €0 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Bausch & Lomb's quarterly accumulated depreciation increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€-1,608 Mil) but then stayed the same from Dec. 2024 (€-1,608 Mil) to Mar. 2025 (€0 Mil).

Bausch & Lomb's annual accumulated depreciation increased from Dec. 2022 (€-1,430 Mil) to Dec. 2023 (€-1,495 Mil) and increased from Dec. 2023 (€-1,495 Mil) to Dec. 2024 (€-1,608 Mil).

Bausch & Lomb Accumulated Depreciation Historical Data

The historical data trend for Bausch & Lomb's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Accumulated Depreciation Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-1,038.19

-1,171.74

-1,430.16

-1,494.71

-1,608.22

Bausch & Lomb Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial														-	-	-	-1,608.22	-

Bausch & Lomb Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Bausch & Lomb Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (STU:S2L) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

BLCO:USA BLCO:Canada

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb Headlines

No Headlines